Valeant Keeps Raising Drug Prices, Stock Still Carries Too Much Risk: Wells Fargo
September 19, 2016 at 09:07 AM EDT
On September 16, Valeant Pharmaceuticals Intl Inc (NYSE: VRX) raised the list price by 9.9 percent each of three of its products, ...
